濮阳东方看妇科价格便宜濮阳东方医院男科价格不高,濮阳市东方医院咨询大夫,濮阳东方医院治早泄口碑好很不错,濮阳东方咨询电话,濮阳东方医院看男科病评价好很不错,濮阳东方医院妇科技术权威,濮阳东方男科医院非常靠谱

CARACAS, March 30 (Xinhua) -- The number of confirmed cases of the A/H1N1 influenza in Venezuela has risen to 482 this year, Health Minister Eugenia Sader said on Wednesday.According to the latest report, the state of Merida in southeastern Venezuela has 189 A/H1N1 influenza cases, the biggest number ever reported, which was followed by the Capital District of Caracas with 112 cases. The other 181 cases were confirmed in 17 of 24 Venezuelan states.The first case for this year was reported in Merida earlier this month.Sader said that the Venezuelan government was trying to prevent the spread of the disease. Some 3 million people have been vaccinated against the virus.Three patients infected with the A/H1N1 influenza virus have died in the country this year, according to Sader.The A/H1N1 influenza can cause deadly pneumonia if it is not treated early.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

LOS ANGELES, April 27 (Xinhua) -- Air pollution poses a threat to the health of about 154 million Americans -- or more than half of the U.S. population, the American Lung Association (ALA) said on Wednesday.The air is so polluted in some areas that it is often dangerous to breathe, the ALA said in its annual report on air quality across the United States.About 48 percent of U.S. residents live in counties where smog (ozone) is too high, 20 percent live in areas where there are too many short-term spikes in pollution and six percent live in areas with harmful year-round soot (particle pollution), said the report.About 17 million Americans live in areas afflicted by all three air pollution hazards, the report noted.The report listed California as the most polluted state, where people are breathing some of the worst air.Compared with other states, California has more polluted places, including Los Angeles, Long Beach, Riverside, Bakersfield and Fresno, the report said.Honolulu in Hawaii and Santa Fe-Espanola in New Mexico are the only two cities in the nation that had no days in which smog and soot levels reached unhealthy ranges, making them the cleanest cities in the nation, said the report.Research suggests air pollution threatens human health -- and not just the lungs.Small particles of pollution can lodge deep in the lungs, triggering an inflammatory process that, over time, can spread elsewhere in the body and damage blood vessels and the heart, according to Dr. Norman Edelman, the ALA's chief medical officer.On days in which smog levels spike, there's an increase in hospital admissions for respiratory illnesses, heart attacks and stroke in the two or three days following it, said Michael Jerrett, a professor of environmental health sciences at University of California, Berkeley's School of Public Health.In addition to posing both long-term and short-term risks, pollution can also contribute to low birth weights, diabetes, cardiovascular disease, heart attack, stroke and, ultimately, shorter life spans, he warned.

BEIJING, Feb. 26 (Xinhua) -- China's Ministry of Education said Friday that 34.29 million students graduated from the country's higher-learning institutions between 2006 and 2010.Xu Mei, the ministry's spokeswoman, said the number is even more than that of the graduates in the 20 years prior to 2006 combined."During the 11th five-year plan period (2006-2010), higher education has become even more accessible to the general public. Higher-learning institutions provide a strong support of brain power and human resources to the social and economic development," Xu said.The "Outline of China's National Plan for Medium and Long-Term Education Reform and Development (2010-2020)," which was publicized last year, says "the strategic goals to be attained by 2020 are to basically modernize education; shape a learning society; and turn China into a country rich in human resources."

You can think of NASA's Discovery program as a sort of outer-space American Idol: every few years the agency invites scientists to propose unmanned planetary missions. The projects have to address some sort of fundamental science question, and (this is the tough part) they have to be relatively cheap to pull off — say, half a billion dollars or so. Then the proposals go through a grueling competition before judges who aren't as nasty as Simon Cowell but who are every bit as tough. The one left standing at the end gets the equivalent of a recording contract: NASA supplies the funding and the launch vehicle, and away the winner goes — to orbit Mercury, as the Messenger spacecraft is doing right now; or to rendezvous with a couple of asteroids, as the Dawn mission will start doing this July; or to smash into a comet on purpose, a feat achieved by Deep Impact in 2005, a mission not to be confused with the movie of the same name. Now it's time for the next contenders. NASA has just announced that the first round of the latest Discovery competition is over, with three entries out of 28 moving on to the finals. They are, in increasing distance from Earth: the Geophysical Monitoring Station (GEMS) lander, which would use seismometers to study the interior of Mars; the Comet Hopper, which would do just that, leaping from place to place across the surface of Comet 46P/Wirtanen to see how different parts of the tumbling body react to heating by the sun; and the Titan Mare Explorer (TiME), which would plop into a sea of liquid hydrocarbons on Saturn's moon Titan — the first oceangoing vessel ever to set sail on another world. If you had to come up with a theme that ties all three missions together, it would be "origins." The Titan explorer, for example, will be studying a place that — in a crude way, at least — resembles the early planet Earth at a time when life arose here. Titan, with a thick atmosphere and a bizarro-world form of weather featuring toxic winds and hydrocarbon rain, is home to a mix of complex chemistry, complete with organic molecules. The oceans provide a medium in which the molecules can move around and interact with each other. It's even conceivable, though clearly a long shot, that some form of microscopic life already exists on this frigid moon. The Mars lander, by contrast, would visit a place where the seas — plain water in this case — vanished long ago. But the mission of GEMS goes far deeper than that. By analyzing Marsquakes on the Red Planet, GEMS will try to get a handle on what the interior of Mars is like. Scientists don't currently know whether the planet's core is liquid, like Earth's, or solid, or some mushy consistency in between. It all depends on how efficiently Mars has cooled since it formed 4.5 billion years ago, and that depends in turn on the planet's internal structure. "That's the mission," says Bruce Banerdt, of NASA's Jet Propulsion Laboratory, the lead scientist for GEMS. "We want to understand how Mars was built." Along with sensitive seismographic equipment, GEMS will drill down about 20 ft. (6 m) with a thermometer-equipped probe, trying to figure out how quickly the temperature rises with depth. "That will let us extrapolate all the way down to the center," Banerdt says, "which will tell us how fast Mars is cooling."